28 results on '"van Delden, Otto M"'
Search Results
2. Effect of hepatic artery embolization on liver hypertrophy response in a rabbit liver VX2 tumor model
- Author
-
van Lienden, Krijn P, Hoekstra, Lisette T, van Trigt, Jessica D, Roelofs, Joris J, van Delden, Otto M, and van Gulik, Thomas M
- Published
- 2013
- Full Text
- View/download PDF
3. Intra-operative ultrasound to determine resectability during surgical exploration of primary non-resectable pancreatic cancer following induction chemotherapy
- Author
-
Walma, Marieke S., van Veldhuisen, Eran, van Rijssen, L.B., Busch, Olivier R., Bruijnen, Rutger C., van Delden, Otto M., Mohammad, Nadia Haj, de Hingh, Ignace, Yo, Lonneke S., van Laarhoven, Hanneke W., van Leeuwen, Maarten S., Nio, C.Y., van Santvoort, Hjalmar C., de Vries, Jan, Wessels, Frank J., Wilmink, J.W., Molenaar, I.Q., Besselink, Marc G., and van Lienden, Krijn P.
- Published
- 2018
- Full Text
- View/download PDF
4. Long-term follow-up and risk factors for strictures after hepaticojejunostomy for bile duct injury: An analysis of surgical and percutaneous treatment in a tertiary center.
- Author
-
Booij, Klaske A.C., Coelen, Robert J., de Reuver, Philip R., Besselink, Marc G., van Delden, Otto M., Rauws, Erik A., Busch, Olivier R., van Gulik, Thomas M., and Gouma, Dirk J.
- Abstract
Background Hepaticojejunostomy is commonly indicated for major bile duct injury after cholecystectomy. The debate about the timing of hepaticojejunostomy for bile duct injury persists since data on postoperative outcomes, including postoperative strictures, are lacking. The aim of this study was to analyze short- and long-term outcomes of hepaticojejunostomy for bile duct injury, including risk factors for strictures. Method Analysis of outcome of hepaticojejunostomy in bile duct injury patients referred to a multidisciplinary team. Results Between the years1991 and 2016, 281 patients underwent hepaticojejunostomy for bile duct injury. Clavien-Dindo grade III complications occurred in 31 patients (11%) and 90-day mortality occurred in 2 patients (0.7%). After a median follow-up of 10.5 years (interquartile range 6.7–14.8 years), clinically relevant strictures were found in 37 patients (13.2%). Strictures were treated with percutaneous dilatation in 33 patients (89.2%), and 4 patients (1.4%) were reoperated. The stricture rate in patients undergoing hepaticojejunostomy <14 days, between 14–90 days, and >90 days after bile duct injury was 15.8%, 18.7%, and 9.9%, respectively. The stricture rate for early versus intermediate and late repair did not differ ( P = 0.766 and 0.431, respectively). The stricture rate for repair after 14–90 days, however, was higher compared with repair >90 days after bile duct injury ( P = 0.045). In multivariable analysis male gender was the only independent variable associated with stricture formation (OR 6.7, 95% CI 1.8–25.4, P = 0.005). Conclusion Hepaticojejunostomy is a relatively safe treatment of bile duct injury. Timing of surgery and intermediate repair affect long-term stricture rate; most anastomotic strictures can be treated successfully with percutaneous dilation. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
5. Multimodality treatment of 132 consecutive patients with locally advanced pancreatic cancer
- Author
-
Vogel, Jantien Anne, de Rooij, Thijs, van Lienden, Krijn P., Wilmink, Johanna W., van Laarhoven, Hanneke W., van Hooft, Jeanin E., van Delden, Otto M., Dijkgraaf, Marcel G., Martin, Robert C., II, Busch, Olivier R., and Besselink, Marc G.
- Published
- 2016
- Full Text
- View/download PDF
6. Endobiliary radiofrequency ablation combined with metal stents for malignant biliary obstruction due to perihilar cholangiocarcinoma (RACCOON-p): a prospective pilot study.
- Author
-
Fritzsche, Jeska A., Wielenga, Mattheus C.B., Van Delden, Otto M., Erdmann, Joris I., Fockens, Paul, Klümpen, Heinz-Josef, Ponsioen, Cyriel Y., Van Wanrooij, Roy L.J., and Voermans, Rogier P.
- Subjects
- *
CATHETER ablation , *CHOLANGIOCARCINOMA , *LONGITUDINAL method , *PILOT projects , *METALS - Published
- 2023
- Full Text
- View/download PDF
7. Outcomes of Irreversible Electroporation for Perihilar Cholangiocarcinoma: A Prospective Pilot Study.
- Author
-
Franken, Lotte C., van Veldhuisen, Eran, Ruarus, Alette H., Coelen, Robert J.S., Roos, Eva, van Delden, Otto M., Besselink, Marc G., Klümpen, Heinz-Josef, van Lienden, Krijn P., van Gulik, Thomas M., Meijerink, Martijn R., and Erdmann, Joris I.
- Abstract
Purpose: To investigate the safety and efficacy of percutaneous or open irreversible electroporation (IRE) in a prospective cohort of patients with locally advanced, unresectable perihilar cholangiocarcinoma (PHC).Materials and Methods: In a multicenter Phase I/II study, patients with unresectable PHC due to extensive vascular involvement or N2 lymph node metastases or local recurrence after resection for PHC were included and treated by open or percutaneous IRE combined with palliative chemotherapy (current standard of care). The primary outcome was the number of major adverse events occurring within 90 d after IRE (grade ≥3), and the upper limit was predefined at 60%. Secondary outcomes included technical success rate, hospital stay, and overall survival (OS).Results: Twelve patients (mean age, 63 y ± 12) were treated with IRE. The major adverse event rate was 50% (6 of 12 patients), and no 90-d mortality was observed. All procedures were technically successful, with no intraprocedural adverse events requiring additional interventions. The median OS from diagnosis was 21 mos (95% confidence interval, 15-27 mos), with a 1-y survival rate of 75% after IRE.Conclusions: Percutaneous IRE in selected patients with locally advanced PHC seems feasible, with a major adverse event rate of 50%, which was below the predefined upper safety limit in this prospective study. Future comparative research exploring the efficacy of IRE is warranted. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
8. Chronic pulmonary embolism in Klippel-Trenaunay syndrome.
- Author
-
Douma, Renée A., Oduber, Charlène E.U., Gerdes, Victor E.A., van Delden, Otto M., van Eck-Smit, Berthe L.F., Meijers, Joost C.M., van Beers, Eduard J., Bouma, Berto J., van der Horst, Chantal M.A.M., and Bresser, Paul
- Abstract
Background: Klippel-Trenaunay syndrome (KTS) is characterized by vascular malformations and disturbed soft tissue or bony growth, involving one or more extremities. A high incidence of venous thromboembolism (VTE) has been reported in this disorder, along with cases of belated diagnosed chronic thromboembolic (CTE) pulmonary hypertension (CTEPH). We performed a cross-sectional study to investigate the prevalence of CTE in patients with KTS. Methods: Those from our KTS patient cohort willing to participate were examined with a sequential diagnostic workup including perfusion scintigraphy, computed tomography, and echocardiography. Results: Of 68 patients, 48 patients participated in the study (median age 43 years; 29 [60%] were female). Eleven patients (23%) had an abnormal perfusion scan result, of whom computed tomographic scanning showed signs of CTE in two patients (4.2%; 95% confidence interval [CI] 1.2%-14%); both patients had a history of VTE. Echocardiography showed no signs of CTEPH in these patients. In total, 23 patients (48%; 95% CI 35%-62%) had a history of superficial vein thrombosis and 8 patients (17%; 95% CI 8.7%-30%) had a history of deep vein thrombosis or pulmonary embolism, which was associated with more shortness of breath. Limitations: Echocardiography was only performed in patients with CTE. Conclusion: A large proportion of patients with KTS had a history of VTE. The prevalence of CTE in the total KTS cohort, however, appeared less alarming than previously assumed. Based on these results, we suggest that there is only a limited indication for CTEPH screening among patients with KTS. Nevertheless, awareness for CTEPH remains appropriate, especially among patients presenting with shortness of breath and a history of VTE. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
9. The failure rate of nonoperative management in children with splenic or liver injury with contrast blush on computed tomography: a systematic review.
- Author
-
van der Vlies, Cornelis H., Saltzherr, Teun P., Wilde, Jim C.H., van Delden, Otto M., de Haan, Rob J., and Goslings, J. Carel
- Subjects
LIVER injuries ,TOMOGRAPHY ,SYSTEMATIC reviews ,TREATMENT effectiveness ,SPLEEN injuries ,TREATMENT of children's injuries - Abstract
Abstract: Purpose: Nonoperative management (NOM) is the treatment of choice for hemodymically stable pediatric patients with spleen or liver trauma. The aim of this study was to assess the failure rate of NOM in children with blunt liver and/or splenic injury when a contrast blush is present on a computed tomography (CT) scan. Methods: A systematic review of the literature published between 1985 and 2009 was performed by searching the EMBASE and MEDLINE database for English and German articles. Articles were eligible if they reported the failure rate of NOM with or without angioembolization (AE) in pediatric patients with splenic and/or liver injuries with a contrast blush on CT and included 2 or more trauma patients. Two reviewers independently assessed the eligibility and the quality of the articles and performed the data extraction. Interrater differences were resolved by discussion. Results: Nine studies were included describing 117 pediatric patients. The median sample size was 5 (range, 2-44). Seven studies (including 71 patients) reported a total of 16 patients with failure after NOM without AE. Failure rates across these studies ranged from 4.5% to 100%; the pooled percentage was 28.2% (95% confidence interval, 8.9%-61.3%). The failure percentages after NOM with or without AE ranged from 0 to 100%; the pooled percentage was 21% (95% confidence interval, 7.5%-46.8%). Two studies (including 46 patients) reported a total of 3 patients (6.5%) with failure after NOM with primary AE. Conclusion: Despite the current low level of evidence on failure rate of NOM when a contrast blush is present on CT, we emphasize that there is a significant number of patients in whom NOM fails. We therefore recommend that the management of splenic and hepatic injury in children should not only be based on the physiologic response but should include consideration of the presence of a contrast blush. [Copyright &y& Elsevier]
- Published
- 2010
- Full Text
- View/download PDF
10. Endoscopic and percutaneous preoperative biliary drainage in patients with suspected hilar cholangiocarcinoma.
- Author
-
Kloek, Jaap J., Van der Gaag, Niels A., Aziz, Yalda, Rauws, Erik A. J., Delden, Otto M. van, Lameris, Johan S., Busch, Olivier R. C., Gouma, Dirk J., Gulik, Thomas M. van, van Delden, Otto M, and van Gulik, Thomas M
- Subjects
SURGICAL drainage ,BILIARY tract surgery ,CHOLANGIOCARCINOMA ,CANCER endoscopic surgery ,SURGICAL stents ,PREOPERATIVE care ,RESEARCH ,BILE duct tumors ,RESEARCH methodology ,MEDICAL cooperation ,EVALUATION research ,COMPARATIVE studies ,BILE ducts ,MEDICAL drainage ,CATHETERIZATION ,HEPATECTOMY ,ENDOSCOPY - Abstract
Introduction: Controversy exists over the preferred technique of preoperative biliary drainage (PBD) in patients with hilar cholangiocarcinoma (HCCA) requiring major liver resection. The current study compared outcomes of endoscopic biliary drainage (EBD) and percutaneous transhepatic biliary drainage (PTBD) in patients with resectable HCCA.Methods: One hundred fifteen consecutive patients were explored for HCCA between 2001 and July 2008 and assigned by initial PBD procedure to either EBD or PTBD.Results: Of these patients, 101 (88%) underwent PBD; 90 patients underwent EBD as primary procedure, and 11 PTBD. The technical success rate of initial drainage was 81% in the EBD versus 100% in the PTBD group (P = 0.20). Stent dislocation was similar in the EBD and PTBD groups (23% vs. 20%, P = 0.70). Infectious complications were significantly more common in the endoscopic group (48% vs. 9%, P < 0.05). Patients in the EBD group underwent more drainage procedures (2.8 vs. 1.4, P < 0.01) and had a significantly longer drainage period until laparotomy (mean 15 weeks vs. 11 weeks in the PTBD group; P < 0.05). In 30 patients, EBD was converted to PTBD due to failure of the endoscopic approach.Conclusions: Preoperative percutaneous drainage could outperform endoscopic stent placement in patients with resectable HCCA, showing fewer infectious complications, using less procedures. [ABSTRACT FROM AUTHOR]- Published
- 2010
- Full Text
- View/download PDF
11. Volumetric and functional recovery of the remnant liver after major liver resection with prior portal vein embolization : recovery after PVE and liver resection.
- Author
-
Esschert, Jacomina W. van den, De Graaf, Wilmar, Lienden, Krijn P. van, Busch, Olivier R., Heger, Michal, Delden, Otto M. van, Gouma, Dirk J., Bennink, Roelof J., Laméris, Johan S., Gulik, Thomas M. van, van den Esschert, Jacomina W, van Lienden, Krijn P, van Delden, Otto M, Laméris, Johan S, and van Gulik, Thomas M
- Subjects
PORTAL vein ,TOMOGRAPHY ,META-analysis ,HYPERTROPHY ,LIVER diseases ,LIVER regeneration ,LIVER physiology ,COMPARATIVE studies ,COMPUTED tomography ,CONVALESCENCE ,HEPATECTOMY ,LIVER ,LIVER tumors ,LONGITUDINAL method ,RESEARCH methodology ,MEDICAL cooperation ,RESEARCH ,THERAPEUTIC embolization ,EVALUATION research ,TREATMENT effectiveness ,RETROSPECTIVE studies - Abstract
Introduction: Portal vein embolization is an accepted method to increase the future remnant liver preoperatively. The aim of this study was to assess the effect of preoperative portal vein embolization on liver volume and function 3 months after major liver resection.Materials and Methods: This is a retrospective case-control study. Data were collected of patients who underwent portal vein embolization prior to (extended) right hemihepatectomy and of control patients who underwent the same type of resection without prior portal vein embolization. Liver volumes were measured by computed tomography volumetry before portal vein embolization, before liver resection, and 3 months after liver resection. Liver function was assessed by hepatobiliary scintigraphy before and 3 months after liver resection.Results: Ten patients were included in the embolization group and 13 in the control group. Groups were comparable for gender, age, and number of patients with a compromised liver. The mean future remnant liver volume was 33.0 +/- 8.0% prior to portal vein embolization in the embolization group and 45.6 +/- 9.1% in the control group (p < 0.01). Prior to surgery, there were no significant differences in future remnant liver volume and function between the groups. Three months postoperatively, the mean remnant liver volume was 81.9 +/- 8.9% of the initial total liver volume in the embolization group and 79.4 +/- 11.0% in the control group (p > 0.05). Remnant liver function increased up to 88.1 +/- 17.4% and 83.3 +/- 14% respectively of the original total liver function (p > 0.05).Conclusion: Preoperative portal vein embolization does not negatively influence postoperative liver regeneration assessed 3 months after major liver resection. [ABSTRACT FROM AUTHOR]- Published
- 2009
- Full Text
- View/download PDF
12. Therapeutic options for endoscopic haemostatic failures: the place of the surgeon and radiologist in gastrointestinal tract bleeding.
- Author
-
Busch, Olivier R.C., van Delden, Otto M., and Gouma, Dirk J.
- Subjects
GASTROINTESTINAL hemorrhage ,ENDOSCOPY ,INTERVENTIONAL radiology ,THERAPEUTIC embolization ,SURGERY ,MEDICAL cooperation ,HEALTH care teams - Abstract
The management of gastrointestinal tract bleeding has changed dramatically due to improvements of interventional endoscopy and radiology. The place of the radiologist has become very important, not only for diagnostic modalities but also for therapeutic embolisation to control the bleeding. The place of the surgeon is limited to the situation where both these less invasive techniques have failed to stop the bleeding. For arterial bleeding in the whole GI tract, angiography with subsequent embolisation is performed after failed endoscopy. For variceal bleeding the preferred treatment after endoscopic failure is transjugular intrahepatic portosystemic stent shunting (TIPS). Surgery is only needed in exceptional cases. Embolisation can be performed successfully without compromising the bowel vascularisation or inducing ischaemia, whereas surgery has a high rate of complications and mortality. For treatment of GI bleeding a multidisciplinary team including a gastroenterologist, radiologist and surgeon is mandatory. [Copyright &y& Elsevier]
- Published
- 2008
- Full Text
- View/download PDF
13. Incidence and Management of Biliary Leakage After Hepaticojejunostomy
- Author
-
de Castro, Steve M.M., Kuhlmann, Koert F.D., Busch, Olivier R.C., van Delden, Otto M., Laméris, Johan S., van Gulik, Thomas M., Obertop, Hugo, Gouma, Dirk J., and Laméris, Johan S
- Subjects
BILIOUS diseases & biliousness ,JEJUNOSTOMY ,PANCREATICODUODENECTOMY ,PATIENTS ,MEDICAL research ,LIVER surgery ,TREATMENT of surgical complications ,CHI-squared test ,NONPARAMETRIC statistics ,REOPERATION ,SURGICAL complications ,TREATMENT effectiveness ,DISEASE incidence ,MEDICAL drainage - Abstract
This study analyzes the change in the management of biliary leakage after hepaticojejunostomy. Between 1993 and 2003 all patients (n = 1033) were studied with a hepaticojejunostomy as part of a pancreatoduodenectomy (n = 486), proximal bile duct resection (without liver resection) (n = 35), and biliodigestive bypass for malignant (n = 302) and benign (n = 210) disease. Biliary leakage was defined as the presence of bile-stained fluid (>50 mL) in the abdominal drain more than 24 hours after surgery, proven radiologically or at relaparotomy. The studied patients were divided into two equal periods to analyze the change in management. Overall, 24 of 1033 patients (2.3%) had biliary leakage. In multivariate analysis, a body mass index greater than 35 kg/m
2 (P = .012), endoscopic biliary drainage (P = .044), and an anastomosis on the segmental bile ducts (P < .001) were independent predictors of leakage. Management in the first half of the study period (1993–1998) versus the second half (1999–2003) was maintenance of operatively placed drains (18% vs. 15%, respectively, P = 1.000), percutaneous transhepatic biliary drainage (18% vs. 69%, respectively, P = .012), surgical drainage (55% vs. 8%, respectively, P = .023), and re-hepaticojejunostomy (9% vs. 8%, respectively, P = 1.000). There was no mortality in the patients with biliary leakage. Leakage after a hepaticojejunostomy is a relatively rare complication without mortality and can safely be managed with percutaneous transhepatic biliary drainage. [Copyright &y& Elsevier]- Published
- 2005
- Full Text
- View/download PDF
14. Extrahepatic perfusion and incomplete hepatic perfusion after hepatic arterial infusion pump implantation: incidence and clinical implications.
- Author
-
Filipe, Wills F., Buisman, Florian E., Franssen, Stijn, Krul, Myrtle F., Grünhagen, Dirk J., Bennink, Roel J., Bolhuis, Karen, Bruijnen, Rutger C.G., Buffart, Tineke E., Burgmans, Mark C., van Delden, Otto M., Doornebosch, Pascal G., Gobardhan, Paul D., Graven, Laura, de Groot, Jan Willem B., Grootscholten, Cecile, Hagendoorn, Jeroen, Harmsen, Paul, Homs, Marjolein Y.V., and Klompenhouwer, Elizabeth G.
- Subjects
- *
PERFUSION , *METHYLENE blue , *DRUG infusion pumps , *CARDIAC radionuclide imaging , *MYOCARDIAL perfusion imaging , *SINGLE-photon emission computed tomography - Abstract
This study investigates the incidence of extrahepatic perfusion and incomplete hepatic perfusion at intraoperative methylene blue testing and on postoperative nuclear imaging in patients undergoing hepatic arterial infusion pump (HAIP) chemotherapy. The first 150 consecutive patients who underwent pump implantation in the Netherlands were included. All patients underwent surgical pump implantation with the catheter in the gastroduodenal artery. All patients underwent intraoperative methylene blue testing and postoperative nuclear imaging (99mTc-Macroaggregated albumin SPECT/CT) to determine perfusion via the pump. Patients were included between January-2018 and December-2021 across eight centers. During methylene blue testing, 29.3% had extrahepatic perfusion, all successfully managed intraoperatively. On nuclear imaging, no clinically relevant extrahepatic perfusion was detected (0%, 95%CI: 0.0–2.5%). During methylene blue testing, 2.0% had unresolved incomplete hepatic perfusion. On postoperative nuclear imaging, 8.1% had incomplete hepatic perfusion, leading to embolization in only 1.3%. Methylene blue testing during pump placement for intra-arterial chemotherapy identified extrahepatic perfusion in 29.3% of patients, but could be resolved intraoperatively in all patients. Postoperative nuclear imaging found no clinically relevant extrahepatic perfusion and led to embolization in only 1.3% of patients. The role of routine nuclear imaging after HAIP implantation should be studied in a larger cohort. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
15. Recurrent cholangitis in patients with a non-stenotic hepaticojejunostomy: incidence and risk factors.
- Author
-
Overdevest, Anouk G., Fritzsche, Jeska A., Smit, Mark A.D., Besselink, Marc G., Bonomi, Alessandro M., Busch, Olivier R., Daams, Freek, van Delden, Otto M., Kazemier, Geert, Langver, Jesse, Ponsioen, Cyriel Y., Swijnenburg, Rutger-Jan, van Wanrooij, Roy L.J., Wielenga, Mattheus C.B., Zonderhuis, Babs M., Zijlstra, IJsbrand A.J., Erdmann, Joris I., and Voermans, Rogier P.
- Subjects
- *
CHOLANGITIS , *JEJUNOSTOMY , *UNIVARIATE analysis , *LOGISTIC regression analysis , *PANCREATIC surgery - Abstract
Cholangitis is a well-known complication after hepaticojejunostomy (HJ), which is mainly caused by a stenotic anastomosis. However, the rate of cholangitis in patients with a non-stenotic (i.e. patent) HJ is unknown. We aimed to evaluate the incidence and risk factors of recurrent cholangitis in patients with a non-stenotic HJ. This single-center retrospective cohort study included all consecutive patients who had undergone hepatobiliary or pancreatic (HPB) surgery requiring HJ (2015–2022). Primary outcome was recurrent non-stenotic cholangitis, risk factors for recurrent non-stenotic cholangitis were identified using logistic regression. Overall, 835 patients with a HJ were included of whom 31/698 (4.4%) patients developed recurrent cholangitis with a non-stenotic HJ during a median follow-up of 34 months (IQR 22–50) and 98/796 (12.3%) patients developed a symptomatic HJ stenosis. These 31 patients experienced 205 cholangitis episodes, median 7.0 (IQR 3.8–8.8) per patient, and 71/205 (34.6%) cholangitis episodes required hospitalization. Male sex (aOR 3.17 (95% CI: 1.34–7.49)) and benign disease (aOR 2.97, 95% CI 1.40–6.33) were identified as risk factors for recurrent cholangitis in non-stenotic HJ in both univariate and multivariable analysis. This study shows that 4% of patients developed recurrent cholangitis without an underlying HJ stenosis. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
16. Transarterial Chemoembolization With Drug-Eluting Beads Versus Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Outcomes From a Multicenter, Randomized, Phase 2 Trial (the TRENDY Trial).
- Author
-
Méndez Romero, Alejandra, van der Holt, Bronno, Willemssen, Francois E.J.A., de Man, Rob A., Heijmen, Ben J.M., Habraken, Steven, Westerveld, Henrike, van Delden, Otto M., Klümpen, Heinz-Josef, Tjwa, Eric T.T.L., Braam, Pètra M., Jenniskens, Sjoerd F.M., Vanwolleghem, Thomas, Weytjens, Reinhilde, d'Archambeau, Olivier, de Vos-Geelen, Judith, Buijsen, Jeroen, van der Leij, Christiaan, den Toom, Wilhelm, and Sprengers, Dave
- Subjects
- *
CHEMOEMBOLIZATION , *STEREOTACTIC radiotherapy , *HEPATOCELLULAR carcinoma - Abstract
To compare transarterial chemoembolization delivered with drug eluting beads (TACE-DEB) with stereotactioc body radiation therapy (SBRT) in patients with hepatocellular carcinoma (HCC) in a multicenter randomized trial. Patients were included if they were eligible for TACE. They could also be recruited if they required treatment prior to liver transplantation. A maximum of four TACE-DEB procedures and ablation after incomplete TACE-DEB were both allowed. SBRT was delivered in six fractions of 8-9Gy. Primary end point was time to progression (TTP). Secondary endpoints were local control (LC), overall survival (OS), response rate (RR), toxicity, and quality of life (QoL). The calculated sample size was 100 patients. Between May 2015 and April 2020, 30 patients were randomized to the study. Due to slow accrual the trial was closed prematurely. Two patients in the SBRT arm were considered ineligible leaving 16 patients in the TACE-DEB arm and 12 in the SBRT arm. Median follow-up was 28.1 months. Median TTP was 12 months for TACEDEB and 19 months for SBRT (p=0.15). Median LC was 12 months for TACE-DEB and >40 months (not reached) for SBRT (p=0.075). Median OS was 36.8 months for TACEDEB and 44.1 months for SBRT (p=0.36). A post-hoc analysis showed 100% for SBRT 1- and 2-year LC, and 54.4% and 43.6% for TACE-DEB (p=0.019). Both treatments resulted in RR>80%. Three episodes of possibly related toxicity grade ≥3 were observed after TACE-DEB. No episodes were observed after SBRT. QoL remained stable after both treatment arms. In this trial, TTP after TACE-DEB was not significantly improved by SBRT, while SBRT showed higher local antitumoral activity than TACE-DEB, without detrimental effects on OS, toxicity and QoL. To overcome poor accrual in randomized trials that include SBRT, and to generate evidence for including SBRT in treatment guidelines, international cooperation is needed. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
17. Long-term efficacy of metal versus plastic stents in inoperable perihilar cholangiocarcinoma; a multicenter retrospective propensity score matched comparison.
- Author
-
Fritzsche, Jeska A., de Jong, David M., Borremans, Jasmijn J.M.M., Bruno, Marco J., Van Delden, Otto M., Erdmann, Joris I., Fockens, Paul, de Gooyer, Peter G.M., Groot Koerkamp, Bas, Klümpen, Heinz-Josef, Moelker, Adriaan, Montazeri, Nahid S.M., Nooijen, Lynn E., Ponsioen, Cyriel Y., Van Wanrooij, Roy L.J., van Driel, Lydi M.J.W., and Voermans, Rogier P.
- Subjects
- *
PROPENSITY score matching , *CHOLANGIOCARCINOMA , *PLASTICS , *METALS - Abstract
For palliative drainage of inoperable perihilar cholangiocarcinoma (pCCA) uncovered metal stents are preferred over plastic stents. However, there is a lack of data on re-interventions at the long-term. The aim is to evaluate the potential difference in the number of re-interventions in patients surviving at least 6 months. Retrospective study including patients with pCCA who underwent plastic stent placement(s) or had metal stent(s) in situ for at least 6 months. The primary outcome was the number of re-interventions per patient-year. A propensity score matching (1:1) analysis was performed using age, Bismuth classification, reason for inoperability, pathological confirmation, systemic therapy and initial approach (endoscopic vs percutaneous). Patients in the metal stent group (n = 87) underwent fewer re-interventions compared with the plastic stent group (n = 40) (3.0 vs. 4.7 per patient-year; IRR, 0.64; 95% CI, 0.47 to 0.88). When only non-elective re-interventions were included, there was no significant difference (2.1 vs. 2.7; IRR, 0.76; 95% CI, 0.55 to 1.08). Results were similar in the propensity score-matched dataset. This study shows that, also in patients with inoperable pCCA who survive at least 6 months, placement of metal stent(s) leads to fewer re-interventions in comparison with plastic stents. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
18. Long-term follow-up of a randomized trial of biliary drainage in perihilar cholangiocarcinoma.
- Author
-
Nooijen, Lynn E., Franssen, Stijn, Buis, Carlijn I., Dejong, Cornelis H.C., den Dulk, Marcel, van Delden, Otto M., Ijzermans, Jan N., Groot Koerkamp, Bas, Kazemier, Geert, van Lienden, Krijn, Klümpen, Heinz-Josef, Kuipers, Hendrien, Olij, Bram, Porte, Robert J., Rauws, Erik A., Voermans, Rogier P., van Gulik, Thomas M., Erdmann, Joris I., Roos, E., and Coelen, R.J.
- Subjects
- *
DRAINAGE , *CHOLANGIOCARCINOMA , *RANDOMIZED controlled trials - Abstract
The DRAINAGE trial was a randomized controlled trial comparing preoperative endoscopic (EBD) and percutaneous biliary drainage (PTBD) in patients with potentially resectable, perihilar cholangiocarcinoma (pCCA). The aim of this study was to compare the long-term outcomes. Patients were randomized in four tertiary referral centers. Follow-up data were available for all included patients. Primary outcome was overall survival (OS). Secondary outcomes were readmissions, and re-interventions not including in-trial interventions. A total of 54 patients were randomized; 27 in both groups. Median follow-up for both groups was 62 months (95% CI 54–70). The median OS was 13 months (95% CI 7.9–18.1) in the EBD and 7 months (95% CI 0.0–17.2) in the PTBD group (P = 0.28). Twenty (37%, n = 8 EBD vs n = 12 PTBD, P = 0.43) of 54 patients were readmitted at least once, mostly due to drainage-related complications (n = 13, 24%). Of note, 14 out of the 54 patients died within the trial. A total of 76 drainage procedures (32 EBD and 44 PTBD) were performed in 28 patients. The median number of stent or drain placements was 2 (2–4) for the EBD group and 2 (1–3) for the PTBD group (P = 0.77). Although this follow-up study represented a small cohort, no long-term differences in survival, readmissions, and drainage procedures for EBD and PTBD were found, even when comparing the resected and unresected group. However, this study demonstrates the complexity of biliary drainage for patients with potentially resectable pCCA, even in tertiary referral centers. [Display omitted] [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
19. Preoperative Biliary Drainage in Patients with Resectable Hilar Cholangiocarcinoma: Endoscopic or Percutaneous Approach?
- Author
-
Kloek, Jaap, Van Der Gaag, Niels, Rauws, Erik, Van Delden, Otto M., Lameris, Han, Busch, Olivier R., Gouma, Dirk J., and Van Gulik, Thomas M.
- Published
- 2009
- Full Text
- View/download PDF
20. Biliopancreatic and biliary leak after pancreatoduodenectomy treated by percutaneous transhepatic biliary drainage.
- Author
-
Henry, Anne Claire, Smits, F. Jasmijn, van Lienden, Krijn, van den Heuvel, Daniel A.F., Hofman, Lieke, Busch, Olivier R., van Delden, Otto M., Zijlstra, IJsbrand A., Schreuder, Sanne M., Lamers, Armand B., van Leersum, Marc, van Strijen, Marco J.L., Vos, Jan A., Te Riele, Wouter W., Molenaar, I. Quintus, Besselink, Marc G., and van Santvoort, Hjalmar C.
- Subjects
- *
PANCREATICODUODENECTOMY , *PANCREATIC surgery , *PANCREATIC fistula , *HOSPITAL mortality , *JEJUNOSTOMY , *CHOLANGITIS - Abstract
Complementary to percutaneous intra-abdominal drainage, percutaneous transhepatic biliary drainage (PTBD) might ameliorate healing of pancreatic fistula and biliary leakage after pancreatoduodenectomy by diversion of bile from the site of leakage. This study evaluated technical and clinical outcomes of PTBD for this indication. All patients undergoing PTBD for leakage after pancreatoduodenectomy were retrospectively evaluated in two tertiary pancreatic centers (2014–2019). Technical success was defined as external biliary drainage. Clinical success was defined as discharge with a resolved leak, without additional surgical interventions for anastomotic leakage other than percutaneous intra-abdominal drainage. Following 822 pancreatoduodenectomies, 65 patients (8%) underwent PTBD. Indications were leakage of the pancreaticojejunostomy (n = 25; 38%), hepaticojejunostomy (n = 15; 23%) and of both (n = 25; 38%). PTBD was technically successful in 64 patients (98%) with drain revision in 40 patients (63%). Clinical success occurred in 60 patients (94%). Leakage resolved after median 33 days (IQR 21–60). PTBD related complications occurred in 23 patients (35%), including cholangitis (n = 14; 21%), hemobilia (n = 7; 11%) and PTBD related bleeding requiring re-intervention (n = 4; 6%). In hospital mortality was 3% (n = 2). Although drain revisions and complications are common, PTBD is highly feasible and appears to be effective in the treatment of biliopancreatic leakage after pancreatoduodenectomy. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
21. Liver function after combined selective internal radiation therapy or sorafenib monotherapy in advanced hepatocellular carcinoma.
- Author
-
Ricke, Jens, Schinner, Regina, Seidensticker, Max, Gasbarrini, Antonio, van Delden, Otto M., Amthauer, Holger, Peynircioglu, Bora, Bargellini, Irene, Iezzi, Roberto, De Toni, Enrico N., Malfertheiner, Peter, Pech, Maciej, and Sangro, Bruno
- Subjects
- *
HEPATOCELLULAR carcinoma , *RADIOTHERAPY , *SORAFENIB , *TREATMENT effectiveness , *LIVER , *PROGNOSIS - Abstract
SORAMIC is a previously published randomised controlled trial assessing survival in patients with advanced hepatocellular carcinoma who received sorafenib with or without selective internal radiation therapy (SIRT). Based on the per-protocol (PP) population, we assessed whether the outcome of patients receiving SIRT+sorafenib vs. sorafenib alone was affected by adverse effects of SIRT on liver function. The PP population consisted of 109 (SIRT+sorafenib) vs. 173 patients (sorafenib alone). Comparisons were made between subgroups who achieved a significant survival benefit or trend towards improved survival with SIRT and the inverse group without a survival benefit: <65 years-old vs. ≥65 years-old, Child-Pugh 5 vs. 6, no transarterial chemoembolisation (TACE) vs. prior TACE, no cirrhosis vs. cirrhosis, non-alcohol- vs. alcohol-related aetiology. The albumin-bilirubin (ALBI) score was used to monitor liver function over time during follow-up. ALBI scores increased in all patient groups during follow-up. In the PP population, ALBI score increases were higher in the SIRT+sorafenib than the sorafenib arm (p = 0.0021 month 4, p < 0.0001 from month 6). SIRT+sorafenib conferred a survival benefit compared to sorafenib alone in patients aged <65 years-old, those without cirrhosis, those with Child-Pugh 5, and those who had not received TACE. A higher increase in ALBI score was observed in the inverse subgroups in whom survival was not improved by adding SIRT (age ≥65 years-old, p < 0.05; cirrhosis, p = 0.07; Child-Pugh 6, p < 0.05; prior TACE, p = 0.08). SIRT frequently has a negative, often subclinical, effect on liver function in patients with hepatocellular carcinoma, which may impair prognosis after treatment. Careful patient selection for SIRT as well as prevention of clinical and subclinical liver damage by selective treatments, high tumour uptake ratio, and medical prophylaxis could translate into better efficacy. EudraCT 2009-012576-27, NCT01126645 This study of treatments in patients with hepatocellular carcinoma found that selective internal radiation therapy (SIRT) has an adverse effect on liver function that may affect patient outcomes. Patients should be carefully selected before they undergo SIRT and the treatment technique should be optimised for maximum protection of non-target liver parenchyma. [Display omitted] • SORAMIC is an RCT assessing survival in patients with advanced HCC receiving sorafenib with or without SIRT. • We assessed whether outcome was affected by the effects of SIRT on liver function. • Albumin-bilirubin (ALBI) score increases were higher in the SIRT+sorafenib vs. sorafenib arm. • Patients showing a trend to or significant survival benefit from SIRT+sorafenib vs. sorafenib had stable liver function. • We conclude SIRT has a negative effect on liver function that may impair prognosis after treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
22. Hospital variation in combined liver resection and thermal ablation for colorectal liver metastases and impact on short-term postoperative outcomes: a nationwide population-based study.
- Author
-
Elfrink, Arthur K.E., Nieuwenhuizen, Sanne, van den Tol, M. Petrousjka, Burgmans, Mark C., Prevoo, Warner, Coolsen, Marielle M.E., van den Boezem, Peter B., van Delden, Otto M., Hagendoorn, Jeroen, Patijn, Gijs A., Leclercq, Wouter K.G., Liem, Mike S.L., Rijken, Arjen M., Verhoef, Cornelis, Kuhlmann, Koert F.D., Ruiter, Simeon J.S., Grünhagen, Dirk J., Klaase, Joost M., Kok, Niels F.M., and Meijerink, Martijn R.
- Subjects
- *
LIVER metastasis , *PROPENSITY score matching , *LIVER surgery , *HOSPITALS , *LIVER , *LOGISTIC regression analysis - Abstract
Combining resection and thermal ablation can improve short-term postoperative outcomes in patients with colorectal liver metastases (CRLM). This study assessed nationwide hospital variation and short-term postoperative outcomes after combined resection and ablation. In this population-based study, all CRLM patients who underwent resection in the Netherlands between 2014 and 2018 were included. After propensity score matching for age, ASA-score, Charlson-score, diameter of largest CRLM, number of CRLM and earlier resection, postoperative outcomes were compared. Postoperative complicated course (PCC) was defined as discharge after 14 days or a major complication or death within 30 days of surgery. Of 4639 included patients, 3697 (80%) underwent resection and 942 (20%) resection and ablation. Unadjusted percentage of patients who underwent resection and ablation per hospital ranged between 4 and 44%. Hospital variation persisted after case-mix correction. After matching, 734 patients remained in each group. Hospital stay (median 6 vs. 7 days, p = 0.011), PCC (11% vs. 14.7%, p = 0.043) and 30-day mortality (0.7% vs. 2.3%, p = 0.018) were lower in the resection and ablation group. Differences faded in multivariable logistic regression due to inclusion of major hepatectomy. Significant hospital variation was observed in the Netherlands. Short-term postoperative outcomes were better after combined resection and ablation, attributed to avoiding complications associated with major hepatectomy. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
23. Systematic review on percutaneous aspiration and sclerotherapy versus surgery in symptomatic simple hepatic cysts.
- Author
-
Furumaya, Alicia, van Rosmalen, Belle V., de Graeff, Jan Jaap, Haring, Martijn P.D., de Meijer, Vincent E., van Gulik, Thomas M., Verheij, Joanne, Besselink, Marc G., van Delden, Otto M., and Erdmann, Joris I.
- Subjects
- *
SCLEROTHERAPY , *QUALITY of life , *SYMPTOMS , *LAPAROSCOPIC surgery , *SURGERY - Abstract
Simple hepatic cysts (SHC) may cause pain and bloating and thus impair quality of life. Whereas current guidelines recommend laparoscopic cyst deroofing, percutaneous aspiration and sclerotherapy (PAS) may be used as a less invasive alternative. This review aimed to assess the efficacy of PAS and surgical management in patients with symptomatic SHC. A systematic search in PubMed and Embase was performed according to PRISMA-guidelines. Studies reporting symptoms were included. Methodological quality was assessed by the MINORS-tool. Primary outcomes were symptom relief, symptomatic recurrence and quality of life, for which a meta-analysis of proportions was performed. In total, 736 patients from 34 studies were included of whom 265 (36%) underwent PAS, 348 (47%) laparoscopic cyst deroofing, and 123 (17%) open surgical management. During weighted mean follow-up of 26.1, 38.2 and 21.3 months, symptoms persisted in 3.5%, 2.1%, 4.2%, for PAS, laparoscopic and open surgical management, respectively. Major complication rates were 0.8%, 1.7%, and 2.4% and cyst recurrence rates were 0.0%, 5.6%, and 7.7%, respectively. Outcomes of PAS for symptomatic SHC appear to be excellent. Studies including a step-up approach which reserves laparoscopic cyst deroofing for symptomatic recurrence after one or two PAS procedures are needed. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
24. Added value of intra-operative ultrasound to determine the resectability of locally advanced pancreatic cancer following FOLFIRINOX chemotherapy (IMAGE): a prospective multicenter study.
- Author
-
van Veldhuisen, Eran, Walma, Marieke S., van Rijssen, L. Bengt, Busch, Olivier R., Bruijnen, Rutger C.G., van Delden, Otto M., Mohammad, Nadia Haj, de Hingh, Ignace H., Yo, Lonneke S., van Laarhoven, Hanneke W., van Leeuwen, Maarten S., Nio, C. Yung, van Santvoort, Hjalmar C., de Vries, Jan, Wessels, Frank J., Wilmink, Johanna W., Molenaar, I. Quintus, Besselink, Marc G., and van Lienden, Krijn P.
- Subjects
- *
PANCREATIC cancer , *LONGITUDINAL method , *CANCER chemotherapy - Abstract
Determining the resectability of locally advanced pancreatic cancer (LAPC) after FOLFIRINOX chemotherapy is challenging because CT-scans cannot reliably assess vascular involvement. This study evaluates the added value of intra-operative ultrasound (IOUS) in LAPC following FOLFIRINOX induction chemotherapy. Prospective multicenter study in patients with LAPC who underwent explorative laparotomy with IOUS after FOLFIRINOX chemotherapy. Resectability was defined according to the National Comprehensive Cancer Network guidelines. IOUS findings were compared with preoperative CT-scans and pathology results. CT-staging in 38 patients with LAPC after FOLFIRINOX chemotherapy defined 22 patients LAPC, 15 borderline resectable and one resectable. IOUS defined 19 patients LAPC, 13 borderline resectable and six resectable. In 12/38 patients, IOUS changed the resectability status including five patients from borderline resectable to resectable and five patients from LAPC to borderline resectable. Two patients were upstaged from borderline resectable to LAPC. Tumor diameters were significantly smaller upon IOUS (31.7 ± 9.5 mm versus 37.1 ± 10.0 mm, p = 0.001) and resectability varied significantly (p = 0.043). Ultimately, 20 patients underwent resection of whom 14 were evaluated as (borderline) resectable on CT-scan, and 17 on IOUS. This prospective study demonstrates that IOUS may change the resectability status up to a third of patients with LAPC following FOLFIRINOX chemotherapy. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
25. Impact of expanding indications on surgical and oncological outcome in 1434 consecutive pancreatoduodenectomies.
- Author
-
van Roessel, Stijn, Mackay, Tara M., Tol, Johanna A.M.G., van Delden, Otto M., van Lienden, Krijn P., Nio, Chung Y., Phoa, Saffire S.K.S., Fockens, Paul, van Hooft, Jeanin E., Verheij, Joanne, Wilmink, Johanna W., van Gulik, Thomas M., Gouma, Dirk J., Busch, Olivier R., and Besselink, Marc G.
- Subjects
- *
PANCREATIC cancer , *PANCREATIC fistula , *HOSPITAL mortality , *GASTRIC emptying , *OLDER patients , *SURGICAL indications , *PANCREATECTOMY - Abstract
Over the years, high-volume pancreatic centers expanded their indications for pancreatoduodenectomy (PD) but with unknown impact on surgical and oncological outcome. All consecutive PDs performed between 1992–2017 in a single pancreatic center were identified from a prospectively maintained database and analyzed according to three time periods. In total, 1434 patients underwent PD. Over time, more elderly patients underwent PD (P < 0.001) with increased use of vascular resection (10.4 to 16.0%, P < 0.001). In patients with cancer (n = 1049, 74.8%), the proportion pT3/T4 tumors increased from 54.3% to 70.6% over time (P < 0.001). The postoperative pancreatic fistula (16.0%), postpancreatectomy hemorrhage (8.0%) and delayed gastric emptying (31.0%) rate did not reduce over time, whereas median length of stay decreased from 16 to 12 days (P < 0.001). The overall failure-to-rescue rate (6.9%) and in-hospital mortality (2.2%) remained stable (P = 0.89 and P = 0.45). In 523 patients with pancreatic cancer (36.5%), the use of both adjuvant and neoadjuvant chemotherapy increased over time (both p<0.001), and the five-year overall survival improved from 11.0% to 17.4% (P < 0.001). In a period where indications for PD expanded, with more elderly patients, more advanced cancers and increased use of vascular resections, surgical outcome remained favorable and five-year survival for pancreatic cancer improved. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
26. The need for pelvic angiographic embolisation in stable pelvic fracture patients with a "blush" on computed tomography.
- Author
-
Verbeek, Diederik O, Ponsen, Kornelis J, van Delden, Otto M, and Goslings, J Carel
- Published
- 2014
- Full Text
- View/download PDF
27. Acute Aortic Syndrome and Blunt Traumatic Aortic Injury: Pictorial review of MDCT imaging
- Author
-
Berger, Ferco H., van Lienden, Krijn P., Smithuis, Robin, Nicolaou, Savvas, and van Delden, Otto M.
- Subjects
- *
BLUNT trauma , *AORTA injuries , *AORTA radiography , *MEDICAL radiology , *MORTALITY , *TOMOGRAPHY , *EMERGENCY medical services - Abstract
Abstract: Thoracic aortic emergencies have high mortality and morbidity and should be diagnosed accurately and treated promptly. Advances in treatment options have increased survival and management choices heavily depend on imaging findings. Speed, accuracy and availability have made Multi Detector Computer Tomography (MDCT) the first line modality in evaluating thoracic aortic emergencies and radiologists should be familiar with findings in these conditions. In this paper a pictorial review of the Acute Aortic Syndrome and Blunt Traumatic Aortic Injury will be given. [Copyright &y& Elsevier]
- Published
- 2010
- Full Text
- View/download PDF
28. Feasibility and safety of irreversible electroporation (IRE) in patients with small renal masses: Results of a prospective study.
- Author
-
Buijs, Mara, Zondervan, Patricia J., de Bruin, Daniel M., van Lienden, Krijn P., Bex, Axel, and van Delden, Otto M.
- Subjects
- *
ELECTROPORATION , *ELECTROPORATION therapy , *RENAL cell carcinoma , *LONGITUDINAL method , *KIDNEY surgery , *BIOPSY , *COMPARATIVE studies , *CREATININE , *CYTOLOGY , *KIDNEYS , *KIDNEY tumors , *RESEARCH methodology , *MEDICAL cooperation , *POSTOPERATIVE pain , *RESEARCH , *PILOT projects , *EVALUATION research , *PAIN measurement , *TREATMENT effectiveness , *ABLATION techniques - Abstract
Background: Irreversible electroporation (IRE) has the potential to overcome limitations of thermal ablation, enabling small renal mass (SRM) ablation near vital structures.Purpose: To assess feasibility and safety of percutaneous IRE for the treatment of SRMs.Materials and Methods: This prospective study is a phase 2 trial (NCT02828709) of IRE for patients with SRMs. Primary endpoints are feasibility and safety. Device- and procedural-adverse events were assessed by Clavien-Dindo and Common Terminology Criteria for Adverse Events version 4.0 grading systems. Technical feasibility was assessed by recording the technical success of the procedures. Technical success was evaluated by performing a CT immediately after ablation where complete tumor coverage and nonenhancement were evaluated. Tumor charcateristics and patient characteristics, procedural and anesthesia details, postprocedural events, and perioperative complications were recorded.Results: Ten SRMs were included with a mean tumor size of 2.2 cm (range 1.1-3.9 cm) were treated with IRE. Renal mass biopsies revealed 7 clear cell and 1 papillary renal cell carcinoma. Two renal mass biopsies were nondiagnostic. The median follow-up was 6 months (range 3-12 months). Technical success was achieved in 9 out of 10 cases. One patient had a grade 3 Clavien-Dindo complication (1/10, 95% Confidence interval (CI) 0.0179-0.4041). Mean anesthesia time was 3.7 hours (range 3-5 hours), mean procedural time was 2.1 hours (range 1 hour 45 minutes-2 hours 30 minutes) and mean ablation time was 50 minutes (range 20 minutes-1 hour 45 minutes). The creatinine preoperative and postoperative (1 week, 3 months, 6 months, and 12 months) did not significantly differ. In total, 8 out of 10 cases did not experience postoperative pain.Conclusion: IRE in SRMs is safe and feasible. Renal function is not affected by IRE and postoperative pain is rare. Anesthesia time and procedural time are a potential concern. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.